MDT

87.66

-0.88%↓

VEEV

280.9

-1.16%↓

A

119.22

-1.87%↓

WBA

11.53

+0.52%↑

HQY

101.41

-0.54%↓

MDT

87.66

-0.88%↓

VEEV

280.9

-1.16%↓

A

119.22

-1.87%↓

WBA

11.53

+0.52%↑

HQY

101.41

-0.54%↓

MDT

87.66

-0.88%↓

VEEV

280.9

-1.16%↓

A

119.22

-1.87%↓

WBA

11.53

+0.52%↑

HQY

101.41

-0.54%↓

MDT

87.66

-0.88%↓

VEEV

280.9

-1.16%↓

A

119.22

-1.87%↓

WBA

11.53

+0.52%↑

HQY

101.41

-0.54%↓

MDT

87.66

-0.88%↓

VEEV

280.9

-1.16%↓

A

119.22

-1.87%↓

WBA

11.53

+0.52%↑

HQY

101.41

-0.54%↓

Search

Baxter International Inc

Fechado

SetorSaúde

29.7 -4.32

Visão Geral

Variação de preço das ações

24h

Atual

Mín

29.53

Máximo

31.04

Indicadores-chave

By Trading Economics

Rendimento

552M

64M

Vendas

-128M

2.6B

P/E

Médio do Setor

124.8

40.527

Rendimento de Dividendos

2.24

Margem de lucro

2.438

Funcionários

38,000

EBITDA

501M

325M

Recomendações

By TipRanks

Recomendações

Neutro

Previsão para 12 meses

+13.58% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

2.24%

2.40%

Próximos Ganhos

5 de ago. de 2025

Próxima data de dividendos

30 de set. de 2025

Próxima data de ex-dividendo

29 de ago. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-175M

16B

Abertura anterior

34.02

Fecho anterior

29.7

Sentimento de Notícias

By Acuity

20%

80%

60 / 375 Ranking em Healthcare

Pontuação Técnica

By Trading Central

Confiança

Weak Bullish Evidence

Baxter International Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

7 de jul. de 2025, 15:29 UTC

Grandes Movimentos do Mercado

Mustang Bio Shares Jump After Orphan Drug Designation for Cancer Treatment

7 de jul. de 2025, 23:44 UTC

Conversa de Mercado

Nikkei May Fall on U.S. Tariff Concerns -- Market Talk

7 de jul. de 2025, 23:44 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

7 de jul. de 2025, 23:41 UTC

Conversa de Mercado

Gold Edges Lower Amid Hopes for Possible Trade Agreements -- Market Talk

7 de jul. de 2025, 23:19 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

7 de jul. de 2025, 23:19 UTC

Conversa de Mercado

AML3D Bull Sees Navy Letter Lowering Risks -- Market Talk

7 de jul. de 2025, 22:20 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

7 de jul. de 2025, 22:20 UTC

Conversa de Mercado

AT&T's Fiber Strategy Positions Stock to Outperform -- Market Talk

7 de jul. de 2025, 21:34 UTC

Aquisições, Fusões, Aquisições de Empresas

BlackRock's Latest Acquisition Is a Commercial Real Estate Bet -- Barrons.com

7 de jul. de 2025, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

7 de jul. de 2025, 20:45 UTC

Aquisições, Fusões, Aquisições de Empresas

CoreWeave Is Buying Core Scientific. The CEO Explains Why. -- Barrons.com

7 de jul. de 2025, 20:16 UTC

Conversa de Mercado

Canada Bonds Set to Benefit From Rotation Away U.S. Assets -- Market Talk

7 de jul. de 2025, 19:37 UTC

Conversa de Mercado

U.S. Natural Gas Futures Hold Their Ground -- Market Talk

7 de jul. de 2025, 19:12 UTC

Conversa de Mercado

Oil Futures Shrug Off Bigger OPEC+ Output Increase -- Market Talk

7 de jul. de 2025, 18:33 UTC

Conversa de Mercado

Gold Flat as Investors Assess Market Direction -- Market Talk

7 de jul. de 2025, 18:27 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

7 de jul. de 2025, 16:53 UTC

Ganhos

Freight Stocks Have a Tariff Overhang. Morgan Stanley Says It Could Be Worse. -- Barrons.com

7 de jul. de 2025, 16:30 UTC

Conversa de Mercado

Higher Prices Limit Power Sector's Natural Gas Use -- Market Talk

7 de jul. de 2025, 16:15 UTC

Conversa de Mercado

Global Commodities Roundup: Market Talk

7 de jul. de 2025, 16:05 UTC

Aquisições, Fusões, Aquisições de Empresas

CoreWeave Is Buying Core Scientific. The CEO Explains Why. -- Barrons.com

7 de jul. de 2025, 15:41 UTC

Conversa de Mercado

Gold Futures Fall as Stronger U.S. Dollar Undermines Safe-Haven Demand -- Market Talk

7 de jul. de 2025, 15:41 UTC

Conversa de Mercado

Market Talk Roundup: Latest on U.S. Politics

7 de jul. de 2025, 15:40 UTC

Conversa de Mercado

Base Metal Prices Tick Lower on U.S. Dollar Strength -- Market Talk

7 de jul. de 2025, 15:30 UTC

Conversa de Mercado

Physical Oil Market Stable But Structural Weakness Looms -- Market Talk

7 de jul. de 2025, 15:18 UTC

Conversa de Mercado

BNP Cuts Brent Forecast on U.S. Shale, Iran Supply Resilience -- Market Talk

7 de jul. de 2025, 15:14 UTC

Aquisições, Fusões, Aquisições de Empresas

MicroStrategy Goes a Week Without Buying Bitcoin. Saylor Has Advice for Crypto Traders. -- Barrons.com

7 de jul. de 2025, 15:00 UTC

Aquisições, Fusões, Aquisições de Empresas

GSK Completes Acquisition of Efimosfermin

7 de jul. de 2025, 14:52 UTC

Conversa de Mercado

Dollar Faces Downward Pressures Stemming from Tariffs -- Market Talk

7 de jul. de 2025, 14:51 UTC

Conversa de Mercado

Bullish Factors Lift Oil Despite Downward Pressure -- Market Talk

7 de jul. de 2025, 14:45 UTC

Conversa de Mercado

Saudi Arabia Not Seeking to Take Oil Market Share -- Market Talk

Comparação entre Pares

Variação de preço

Baxter International Inc Previsão

Preço-alvo

By TipRanks

13.58% parte superior

Previsão para 12 meses

Média 35.22 USD  13.58%

Máximo 40 USD

Mínimo 28 USD

Com base em 10 analistas de Wall Street que oferecem metas de preço de 12 meses para Baxter International Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

10 ratings

3

Comprar

6

Manter

1

Vender

Pontuação Técnica

By Trading Central

30.475 / 31.345Suporte e Resistência

Curto Prazo

Weak Bullish Evidence

Médio Prazo

Bearish Evidence

Longo Prazo

Bearish Evidence

Sentimento

By Acuity

60 / 375 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Baxter International Inc

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.